Influence of the COVID-19 Pandemic on Quality of Life of Patients with Parkinson’s Disease

Table 2

Comparison of all PDQ-39 domain outcomes of 108 patients between during and after epidemic prevention and control.

Variables	During epidemic prevention and control	After epidemic prevention and control	t value	Sig
Mobility	20.42 ± 3.37	15.84 ± 3.37	16.961	< 0.001
ADL	12.73 ± 2.36	10.41 ± 2.61	9.174	< 0.001
Emotional well-being	12.51 ± 1.85	9.93 ± 2.42	11.691	< 0.001
Stigma	8.60 ± 1.84	7.36 ± 2.01	6.955	< 0.001
Social support	6.32 ± 1.47	6.06 ± 1.84	1.915	0.058
Cognition	8.39 ± 1.98	6.92 ± 2.07	7.714	< 0.001
Communication	5.95 ± 1.55	5.08 ± 1.76	4.480	< 0.001
Bodily discomfort	6.36 ± 1.68	4.38 ± 1.69	10.345	< 0.001
Total score	81.29 ± 9.09	65.94 ± 8.70	20.363	< 0.001